HOME ZACKS RESEARCH FUNDS PORTFOLIO BROKER RESEARCH MARKETS SCREENING VIDEO EDUCATION SERVICES
Earnings    EPS Surprises    Mutual Funds    Options            My Account    Help    
Quote:
Login Free Membership
Search:

RELATED LINKS
Free Membership
Premium Home
Zacks #1 Rank
Real Time Insight
Equity Research
My Portfolio
Stock Screener
Premium Screens
Mutual Funds
ETFs
RSS Feed
Profit from the Pros
Subscription Services
FTM Trader
Product Guide
Zacks Premium
Method for Trading
Chart Patterns Trader
Home Run Investor
Income Plus
Insider Trader
Options Trader
Reitmeister Trader
Reitmeister Value
Tactical Trader
Top 10 Stocks
Turnaround Trader
Whisper Trader
Research Wizard
Zacks Ultimate



Zacks Premium
Get profitable stock
picks and timely
market advice in
Zacks.com`s Free
Daily Newsletter!

Free Registration

View the Archive


BRLI: BIO REFERENCE LABS INC NEW - Stock Quote Enter Ticker:
 

QuoteEstimatesCharts Company ReportsNewsFinancials
  Quote |  Detailed Quotes |  Real Time |  Options Chain |  Greeks Montage

BIO REFERENCE LABS INC NEW (NASD)
BRLI 20.38 0.04 (0.20%) Vol.  151,120 16:00 ET

Zacks Rank: 2 - Buy

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.
Zacks Rank Definition Annualized Return
# 1Strong Buy26.04%
# 2Buy18.27%
# 3Hold9.49%
# 4Sell3.94%
# 5Strong Sell1.6%
S&P5009.23%
Zacks Rank Education - Learn more about the Zacks Rank
Zacks Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank


Day Low - High 20.15 - 20.77
52wk Low - High 11.41 - 25.99
Avg Volume 160,264
Industry MED/DENTAL-SUPP
Market Cap 565.03 M
Div - Yield 0.00 - 0.00
PE (forward) 14.1
PEG Ratio .81
Current Year Est. 1.44
EPS Last Year 1.25
Detailed Quote


Premium Research: Stock Analysis

Zacks Rank

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.
Zacks Rank Definition Annualized Return
# 1Strong Buy26.04%
# 2Buy18.27%
# 3Hold9.49%
# 4Sell3.94%
# 5Strong Sell1.6%
S&P5009.23%
Zacks Rank Education - Learn more about the Zacks Rank
Zacks Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank


Short-Term Rating 1-3 Months
Zacks #1 Rank Strong Buys Zacks Premium
2 - Buy
Zacks Recommendation

Zacks Recommendations are an excellent predictor of stock price movement over a 6+ month time frame. The recommendations come from the Zacks Equity Research group which combines the Zacks Rank with the insights from their team of over 50 equity analysts. The result is superior long term stock ratings.

The Zacks Recommendations are split into 3 groups: Outperform, Neutral and Underperform. When Zacks Premium members click on the recommendation it will launch them to the Zacks Equity Research report for the stock. More on these reports below.

Difference Between Zacks Rank and Zacks Recommendation
Zacks Equity Research Home
Zacks Premium - The only way to get access to Zacks Recommendations


Long-Term Rating 6+ Months
All Outperform Rated Stocks Zacks Premium
PREMIUM
Zacks Industry Rank

Which industries are set to outperform or underperform the market? You'll find the answer here. We have broken down all industries into over 200 classifications. Then ranked these industries using the most powerful indicator we know (the Zacks Rank). The higher the industry rank, the better the industry should perform in the future. Once you have found an attractive industry then check out the Rank in Industry to find the best stocks within the industry.

When Zacks Premium members click on the Zacks Industry Rank link they will see the full listing of industries and their current rankings.

About Zacks Industry Rank
Zacks Industry Rank - All current industry ranks.
Zacks Premium - The only way to get access to the Zacks Industry Rank

PREMIUM
Target Price

The Zacks Price Target provides you our expectation for a stocks share price in the next 6 months. These price targets are created by the Zacks Equity Research group to coincide with their recommendations that are also based on a 6 month time horizon.

Zacks Equity Research Home
Zacks Premium - The only way to get access to the Zacks Price Targets

PREMIUM
Equity Research Report

The Zacks Recommendations and Zacks Target Prices are just two of the valuable resources you'll find in the reports created by the Zacks Equity Research group. When Zacks Premium members click on this link they will taken to a page that gives them access to the Zacks Equity Research report for the stock.

Zacks Equity Research Home Zacks Premium - The only way to get access to Zacks Recommendations


Updated as of 05/17/2012
PREMIUM
Get all our stock ratings and recommendations with a Free Trial to Zacks Premium

Premium Research: Industry Analysis

Top Peers Ticker Zacks Rank
BIO REFERENCE LABS INC NEW BRLI 2
ALIGN TECH INC ALGN 1
COOPER COS COO 2
STAAR SURGICAL STAA 2
Top Peer Analysis Zacks Premium
See all MED/DENTAL-SUPP Peers

BROKERAGE RECOMMENDATIONS
Current ABR 2.00
ABR (Last Week) 2.00
# of Recs in ABR 4
Average Target Price 25.50
Rank in Industry 19 out of 33
More Brokerage Recommendations


NYSE data is at least 20 minutes delayed.
NASDAQ data is at least 15 minutes delayed.

 Interactive Java Charting
 NEW!   Fundamental Charts




Zacks Community PeopleAndPicks.com
Community Rating

PeopleAndPicks.com Community Stock Ratings

Rating Recommendation % of Stocks
5 stars Strong Buy 10%
4 stars Buy 20%
3 stars Hold 40%
2 stars Sell 20%
1 stars Strong Sell 10%
0 stars Not Rated  

We believe that a community of investors working together can create a superior stock rating system. Some call this "collective intelligence". Or simply...together we can beat the market!

A stock's Community Rating is calculated based on the aggregate input of the PeopleAndPicks Community. The proportion of buy to sell ratings, recency of analysis, and the average score of the users who rate it favorably all factor into a score of one to five stars.


How do you rate BRLI?

Buy Sell
Find out what the Zacks Community
thinks of BRLI at PeopleAndPicks.com
 
ZACKS COMMENTARY FOR BRLI
Zacks Equity Research: Report for BRLI
May 17, 2012
Zacks Blog: Bio-Reference Laboratories Inc. Enters Oversold Territory
Apr 19, 2012
Zacks Blog: Zacks Releases Four Powerful ''Buy'' Stocks: BioReference Laboratories, NiSource, Teradata and Parker Drilling Company
Oct 11, 2011
Aggressive Growth: BioReference Laboratories Inc.
Oct 11, 2011
Zacks Blog: Zacks #1 Rank Additions for Thursday
Sep 29, 2011
Zacks Blog: Zacks.com featured expert Kevin Matras highlights: Bio-Reference Laboratories, Inc. Heartland Payment Systems, Inc., Lithia Motors, Inc., ONEOK Partners, L.P....
Aug 30, 2011
Screen of the Week: Price to Sales Ratio
Aug 30, 2011
Zacks Blog: Zacks Investment Ideas feature highlights: Las Vegas Sands, Coinstar, Gildan Activewear and Bio-Reference Laboratories
Jun 22, 2011
More Zacks Commentary
NEWS
Bio-Reference Laboratories, Inc. (BRLI) Corporate Event Announcement Notice
May 26, 2012
Bio-Reference Laboratories, Inc. (BRLI) Corporate Event Announcement Notice - Story Title - Comtex
May 26, 2012
Bio-Reference Laboratories, Inc. (BRLI) Corporate Event Announcement Notice
May 25, 2012
Bio-Reference Laboratories, Inc. (BRLI) Corporate Event Announcement Notice - Story Title - Comtex
May 25, 2012
Earnings Scheduled For May 25 - Benzinga
May 25, 2012
Bio-Reference Laboratories, Inc. (BRLI) Corporate Event Announcement Notice
May 24, 2012
Bio-Reference Laboratories, Inc. (BRLI) Corporate Event Announcement Notice - Story Title - Comtex
May 24, 2012
Bio Reference Labs (BRLI) Showing Bearish Technicals With Support At $19.75
May 23, 2012
More News
EARNINGS ESTIMATES
  This Quarter
04/2012
Next Quarter
07/2012
This Year
10/2012
Next Year
10/2013
Average Estimate 0.32 0.43 1.44 1.70
Number of Estimates 5 4 5 5
Low Estimates 0.30 0.42 1.40 1.60
High Estimate 0.33 0.45 1.50 1.84
Year Ago EPS 0.26 0.36 1.16 1.44
EPS Growth 21.54% 19.44% 24.31% 17.75%

More Estimates

COMPANY DESCRIPTION
BioReference Laboratories Inc. is the largest independent regional clinical laboratory in the Northeast & has major market positions in physician offices, nursing homes & correctional institutions. The Company is a full service clinical laboratory with specialty capability, especially in the areas of genomics, oncology, correctional health & complimentary medicine. PSIMedica, a business unit of the Company is a clinical knowledge management organization offering an array of information solutions for reducing healthcare costs & improving quality performance that are based on a flexible, scalable software analytical engine that utilizes all available source information including claims data, enrollment data, prescription data & laboratory data. They provides a comprehensive connectivity solution to physicians as well as other laboratories which includes laboratory reporting & ordering as well as laboratory to physician communications & cumulative reporting through CareEvolve its web-based healthcare portal.

Full Company Report
FINANCIALS
EPS TTM 1.25
Sales 558.64
Net Income 35.74
Price/Earnings 16.27
Price/Book 2.93
Price/Cash Flow 11.94
Price/Sales .96


More Financials

 
About Zacks | Advertise | Affiliate | Media | Careers | Contact Us | Help
Disclaimer | Privacy Policy | Sitemap
NYSE and AMEX data is at least 20 minutes delayed.  NASDAQ data is at least 15 minutes delayed.
Copyright 2012 Zacks Investment Research